Funding Opportunities

The NCI Transition Career Development Award (K22)

due: 12-10-2014 Research, Young Investigator NIH PAR-12-121 US Citizen required
This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent.

NIH Director’s New Innovator Award Program (DP2)

due: 17-10-2014 Research NIH RFA-RM-13-007 US Citizen required
The NIH Director’s New Innovator (DP2) Award initiative supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. The New Innovator Award initiative complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators.

NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)

due: 28-10-2014 Research NIH PAR-13-146 US Citizen required
By using the R21 mechanism, this FOA will support exploratory/developmental projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, and/or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical). Applications submitted under this mechanism should have a clear potential to break new ground and/or extend previous discoveries toward new directions or applications. Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. Conversely, long-term projects, or projects designed to increase knowledge in a well-established area, will not be considered for R21 awards.

NCI Small Grants Program for Cancer Research (NCI Omnibus R03)

due: 28-10-2014 Research NIH PAR-14-007 required
This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), of the National Institutes of Health (NIH) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

Macromolecular, Supramolecular and Nanochemistry (MSN)

due: 31-10-2014 Research NSF PD 09-6885 Faculty required
The Macromolecular, Supramolecular and Nanochemistry (MSN) Program focuses on basic research that addresses fundamental questions regarding the chemistry of macromolecular, supramolecular and nanoscopic species and other organized structures and that advances chemistry knowledge in these areas. Research of interest to this program will explore novel chemistry concepts in the following topics: (1) The development of novel synthetic approaches to clusters, nanoparticles, polymers, and supramolecular architectures; innovative surface functionalization methodologies; surface monolayer chemistry; and template-directed synthesis. (2) The study of molecular scale interactions that give rise to macromolecular, supramolecular or nanoparticulate self-assembly into discrete structures; and the study of chemical forces and dynamics that are responsible for spatial organization in discrete organic, inorganic or hybrid systems (excluding extended solids). (3) Investigations that utilize advanced experimental or computational methods to understand or to predict the chemical structure, unique chemical and physicochemical properties, and chemical reactivities that result from the organized or nanoscopic structures. Research in which theory advances e